Cargando…

Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study

The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects 
http://ow.ly/Gaq530o9kEg

Detalles Bibliográficos
Autores principales: Suarez-Cuartin, Guillermo, Molina-Molina, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544796/
https://www.ncbi.nlm.nih.gov/pubmed/31191729
http://dx.doi.org/10.1183/20734735.0016-2019
_version_ 1783423303019397120
author Suarez-Cuartin, Guillermo
Molina-Molina, Maria
author_facet Suarez-Cuartin, Guillermo
Molina-Molina, Maria
author_sort Suarez-Cuartin, Guillermo
collection PubMed
description The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects 
http://ow.ly/Gaq530o9kEg
format Online
Article
Text
id pubmed-6544796
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-65447962019-06-12 Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Suarez-Cuartin, Guillermo Molina-Molina, Maria Breathe (Sheff) Expert Opinion The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects 
http://ow.ly/Gaq530o9kEg European Respiratory Society 2019-06 /pmc/articles/PMC6544796/ /pubmed/31191729 http://dx.doi.org/10.1183/20734735.0016-2019 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Expert Opinion
Suarez-Cuartin, Guillermo
Molina-Molina, Maria
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
title Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
title_full Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
title_fullStr Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
title_full_unstemmed Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
title_short Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
title_sort assessing quality of life of idiopathic pulmonary fibrosis patients: the instage study
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544796/
https://www.ncbi.nlm.nih.gov/pubmed/31191729
http://dx.doi.org/10.1183/20734735.0016-2019
work_keys_str_mv AT suarezcuartinguillermo assessingqualityoflifeofidiopathicpulmonaryfibrosispatientstheinstagestudy
AT molinamolinamaria assessingqualityoflifeofidiopathicpulmonaryfibrosispatientstheinstagestudy